Ligand Pharmaceuticals
LGND
#4097
Rank
$2.27 B
Marketcap
$120.43
Share price
-1.56%
Change (1 day)
74.03%
Change (1 year)

Operating Margin for Ligand Pharmaceuticals (LGND)

Operating Margin as of December 2024 (TTM): 18.35%

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 18.35%. At the end of 2022 the company had an Operating Margin of 18.35%.

Operating Margin history for Ligand Pharmaceuticals from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202218.35%7.52%
202117.07%-401.92%
2020-5.65%-100.85%
2019662.31%860.82%
201868.93%69.95%
201740.56%455.27%
20167.30%-85.13%
201549.13%180.53%
201417.51%-6.85%
201318.80%-252.67%
2012-12.31%26.23%
2011-9.75%-85.09%
2010-65.44%158.12%
2009-25.35%-92.9%
2008-357.00%-13.89%
2007-414.58%235.33%
2006-123.63%-700.84%
200520.58%-174.92%
2004-27.46%102.13%
2003-13.59%-45.63%
2002-24.99%-17.54%
2001-30.31%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.38%-21.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-109.76%-698.15%๐Ÿ‡บ๐Ÿ‡ธ USA
10.36%-43.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
3.14%-82.89%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
24.84% 35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.50%-179.02%๐Ÿ‡บ๐Ÿ‡ธ USA
1.18%-93.57%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-3.65%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.